Confirming our survival analyses, downregulation of miR-22-3p/miR22HG was mostly observed in HCC-bearing TP53 mutations (p = 0.08) but not CTNNB1 mutations (Figure 1F and Figure S1). Here, TP53 is linked to hepatocellular carcinoma.